MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1056/nejmoa050156

Медицинская библиотека · The New England journal of medicine · 2005

Randomized trial of lifestyle modification and pharmacotherapy for obesity.

Wadden Thomas A, Berkowitz Robert I, Womble Leslie G, Sarwer David B, Phelan Suzanne, Cato Robert K, Hesson Louise A, Osei Suzette Y, Kaplan Rosalind, Stunkard Albert J

СтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Weight-loss medications are recommended as an adjunct to a comprehensive program of diet, exercise, and behavior therapy but are typically prescribed with minimal or no lifestyle modification. This practice is likely to limit therapeutic benefits.

METHODS

In this one-year trial, we randomly assigned 224 obese adults to receive 15 mg of sibutramine per day alone, delivered by a primary care provider in eight visits of 10 to 15 minutes each; lifestyle-modification counseling alone, delivered in 30 group sessions; sibutramine plus 30 group sessions of lifestyle-modification counseling (i.e., combined therapy); or sibutramine plus brief lifestyle-modification counseling delivered by a primary care provider in eight visits of 10 to 15 minutes each. All subjects were prescribed a diet of 1200 to 1500 kcal per day and the same exercise regimen.

RESULTS

At one year, subjects who received combined therapy lost a mean (+/-SD) of 12.1+/-9.8 kg, whereas those receiving sibutramine alone lost 5.0+/-7.4 kg, those treated by lifestyle modification alone lost 6.7+/-7.9 kg, and those receiving sibutramine plus brief therapy lost 7.5+/-8.0 kg (P<0.001). Those in the combined-therapy group who frequently recorded their food intake lost more weight than those who did so infrequently (18.1+/-9.8 kg vs. 7.7+/-7.5 kg, P=0.04).

CONCLUSIONS

The combination of medication and group lifestyle modification resulted in more weight loss than either medication or lifestyle modification alone. The results underscore the importance of prescribing weight-loss medications in combination with, rather than in lieu of, lifestyle modification.

Для цитирования: Wadden Thomas A, Berkowitz Robert I, Womble Leslie G, Sarwer David B, Phelan Suzanne, Cato Robert K, Hesson Louise A, Osei Suzette Y, Kaplan Rosalind, Stunkard Albert J. Randomized trial of lifestyle modification and pharmacotherapy for obesity.. The New England journal of medicine. 2005. DOI: 10.1056/nejmoa050156.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.